Skip to main content
logo
Transgene SA (TRGNF)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
Feb 5, 2026, 4:00 PM EST

Transgene Revenue

Transgene had revenue of 4.58M EUR in the half year ending June 30, 2025, a decrease of -3.86%. This brings the company's revenue in the last twelve months to 7.58M, up 16.65% year-over-year. In the year 2024, Transgene had annual revenue of 6.35M, down -19.58%.

Revenue (ttm)
7.58M EUR
Revenue Growth
+16.65%
P/S Ratio
30.76
Revenue / Employee
51.53K EUR
Employees
147
Market Cap
273.60M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.35M-1.55M-19.58%
Dec 31, 20237.90M-2.44M-23.63%
Dec 31, 202210.34M-6.90M-40.00%
Dec 31, 202117.24M7.67M80.08%
Dec 31, 20209.57M-3.72M-28.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioStem Technologies292.21M
Vaxart148.20M
Silence Therapeutics25.83M
Nuo Therapeutics2.61M
Northwest Biotherapeutics937.00K
Arch Biopartners198.11K
Revenue Rankings

Transgene News

More News